Amexdrug Corporation
AXRX
$0.002
$0.000.00%
| 06/30/2013 | 03/31/2013 | 12/31/2012 | 09/30/2012 | 06/30/2012 | |
|---|---|---|---|---|---|
| Net Income | -66.40% | 271.96% | -379.11% | -15.13% | -59.37% |
| Total Depreciation and Amortization | 0.00% | 46.28% | 384.00% | 0.00% | 0.00% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -533.33% | 95.92% | -2,000.00% | -153.85% | 192.86% |
| Change in Net Operating Assets | 121.47% | -158.53% | 200.47% | -329.97% | -23.26% |
| Cash from Operations | 192.20% | -132.29% | 188.74% | -505.13% | -1,268.66% |
| Capital Expenditure | 100.00% | 99.48% | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -69.23% | -- | -- | -- | 100.00% |
| Cash from Investing | 136.36% | 99.76% | -- | -- | 100.00% |
| Total Debt Issued | -- | -- | -101.14% | -- | -- |
| Total Debt Repaid | -257.70% | -- | -- | 471.77% | 114.89% |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | 66.67% | -- | -- | -- | 100.00% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -1,633.33% | -- | -- |
| Cash from Financing | 15.01% | -727.39% | -101.85% | 1,161.96% | 114.86% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 112.62% | -1,693.41% | -93.82% | 1,311.52% | 94.74% |
